|
|
||||||||
1Human Performance Laboratory, Department of Kinesiology, and 2Departments of Physiology and Neurobiology and of Nutritional Sciences, University of Connecticut, Storrs; 3The John B. Pierce Laboratory, Yale University School of Medicine, New Haven, Connecticut; and 4Laboratory of Nutrition and Clinical Dietetics, Harokopio University, Athens, Greece
Submitted 15 February 2005 ; accepted in final form 29 September 2005
| ABSTRACT |
|---|
|
|
|---|
fluid balance; plasma volume; osmoregulation; cycling; vasopressin
However, ingesting a large volume of fluids, even in dehydrated subjects, rapidly decreases arginine vasopressin (AVP), even before plasma volume or osmolality have been restored, leading to increased urinary output (12). Additionally, thirst sensation decreases in response to plasma volume and osmolality restoration, mouth wetness, and oral-pharyngeal stimulation (33). For these reasons, rehydration is a major part of the recovery process after exercise, especially when individuals must undertake repeated bouts of exercise-heat stress.
In 1987, glycerol, used with water, was first shown to induce hyperhydration more efficiently than water alone, and this effect persisted for 4 h (40). More recently, the effect of glycerol-induced hyperhydration on fluid-regulating hormones was investigated (14). The authors demonstrated a small, nonsignificant increase in plasma vasopressin and no change in circulating aldosterone (Aldo) or atrial natriuretic factor. They reported that there may have been a direct glycerol effect on the kidneys that increased fluid reabsorption and induced a positive fluid balance.
Glycerol is a safe agent that does not approach toxic levels when administered orally in doses of <5 g/kg body wt (47). Glycerol also is an attractive compound for use in studies that involve fluid balance and exercise, because it is not a major energy source during intense exercise (15, 32, 34, 37). Furthermore, glycerol-induced hyperhydration has been suggested to 1) increase overall exercise performance (2, 9, 19) or time to exhaustion (36) in both temperate (36) and hot (2, 9, 19) environments; 2) increase sweat rate (28); 3) decrease heart rate (HR) (36) and rectal temperature (Tre) during moderate-intensity cycling exercise (2); and 4) last for 3248 h after dosing (23). However, several other studies have shown no performance (20, 29, 31, 48) or thermoregulatory benefit (9, 19, 25, 26, 31, 36) following glycerol-induced hyperhydration.
The purpose of the present investigation was to examine the effect of partial oral rehydration with glycerol on a subsequent exhaustive exercise test in the heat. Surprisingly, although there is a vast amount of information on the role of glycerol as a hyperhydration agent, very limited information is available on its effect in rehydration (44). We hypothesized that glycerol would stabilize cardiovascular function, reduce heat stress, and enhance exercise capacity after partial rehydration.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Eight endurance-trained male cyclists agreed to serve as subjects in this study. Their mean (±SE) characteristics were as follows: age, 24 ± 1 (range 1929) yr; body mass, 70.1 ± 1 (range 66.773.6) kg; height, 181 ± 2 (range 174185) cm; fat-free mass, 56.6 ± 0.4 (range 52.661.7) kg; and peak O2 uptake (
O2 peak), 61.4 ± 0.8 (range 58.965.9) ml·kg1·min1. Subjects were selected after their physical activity and medical history questionnaires were reviewed, without regard to race or ethnic origin. These men were heat acclimatized, trained regularly, competed in road cycling or mountain bike races, were nonsmokers, and reported no previous history of endocrine, cardiovascular, renal, or thermoregulatory disorders. All athletes had completed their competitive season at least 2 mo before the study and were on their training season. The study was approved by the Institutional Review Board for Studies Involving the Use of Human Subjects at the University of Connecticut, and all volunteers gave their written, informed consent after attending an informational meeting that addressed the study purpose, methods, and attendant risks and benefits.
Preliminary Testing
Body composition. The hydrostatic weighing technique was used to determine body density. Each subject performed the measurement at least 20 times, on 2 separate days, before the actual data were collected. Before this measurement, residual volume was calculated based on the vital capacity measured with a hand-held spirometer. Calculation of the percentage of body fat from body density was based on the Brozek equation (6).
O2 peak test.
O2 peak was determined in a thermocomfortable environment (27°C) using an incremental resistance exercise test on a mechanically braked cycle ergometer (Monark ergomedic 818E, Stockholm, Sweden). The exercise test consisted of continuous cycling at a constant cadence (90100 rpm), while resistance increased by 0.5 kp every 2 min until volitional exhaustion. Breath-by-breath analysis of the expired gases during the test was performed with an open-circuit respiratory apparatus (model CPXD, MedGraphics Cardiopulmonary Exercise System, St. Paul, MN). Two of the following three criteria were used to verify the attainment of
O2 peak: 1) no increase in oxygen uptake (
O2; <150 ml/min) with an increase in ergometer resistance, 2) HR >90% of predicted maximal value (i.e., 220 age), and 3) respiratory exchange ratio >1.1. The average duration of the
O2 peak test was 10.01 ± 0.96 min.
Experimental Protocol
Each subject completed three experimental trials, which differed only with regard to rehydration. The rehydration treatments were as follows: no fluid (NF), which served as a control; glycerol followed by water (G), and water alone (W). To ensure double-blind design, a noncaloric, nonsodium, flavored powder (Kool-Aid, White Plains, NY) was added to both G and W drinks. The experimental treatments were presented in a random sequence to avoid order effect and were separated by a minimum of 1 wk to prevent a carryover effect. Subjects were asked to maintain similar eating and training habits during the 3 days before each trial, verified by 3-day dietary intake and physical training records.
Euhydration baseline. Subjects reported to the laboratory between 1000 and 1200 in a euhydrated state, having ingested at least 30 ml/kg of their body weight of water (or other noncaffeinated fluids) during the previous day. After each subject emptied his bladder, urine specific gravity (USG) was determined by refractometry to verify good hydration status (<1.020), and baseline euhydrated body weight was recorded to ±50 g (SRI, Instruments Precision Scales, Tonawanda, NY). Hydration status also was verified by plasma (OsmP = 285295 mosmol/kgH2O) and urine osmolality (Osmu < 900 mosmol/kgH2O). The subjects entered the environmental chamber (model 2000, Minus Eleven, Malden, MA; ambient temperature, 36.7 ± 0.2°C; relative humidity, 48.0 ± 1.2%) and sat for 20 min before a blood sample was taken without stasis using a 20-gauge butterfly needle.
Dehydration. Following euhydration baseline, and for the remainder of the day, subjects underwent fluid restriction and consumed food low in fluid content for lunch and dinner. Additionally, during the afternoon and evening of this day, subjects performed 2 h of low-intensity cycling exercise to induce a body fluid loss equivalent to 4% of body weight.
Dehydration baseline. The subject arrived at the laboratory 12 h postprandial, emptied his bladder, and had body weight measured to verify the degree of dehydration. If dehydration was <3.5 or >4.5%, the experiment was canceled for that day (see Table 1). USG also was recorded to verify hypohydration. A 20-gauge, 32-mm indwelling Teflon catheter was inserted in an antecubital vein, and an extension tube with a stopcock was attached to the catheter port for acquisition of serial blood samples. The catheter was kept patent by flushing isotonic saline solution containing 20 heparin units/ml of solution. From that point on, the subject remained seated in a wheelchair. Subjects were taken into the environmental chamber (36.7 ± 0.2°C), and, after 20 min of equilibration, a blood sample (25 ml) was taken.
|
Exercise test.
Following the blood sample, subjects sat on a mechanically braked cycle ergometer (Monark ergomedic 818E). Seat height was the same for all trials, and toe clips were used. The exercise test (time to exhaustion expressed in minutes) consisted of steady-state cycling (74.0 ± 1.1%
O2 peak) at 80100 rpm. Subjects continued cycling until one of the following criteria for termination were met: inability to maintain cadence (decrease by >20 rpm), increase in Tre to 39.5°C for >5 min, or signs or symptoms of heat exhaustion. The following ambient conditions were maintained in the climatic chamber during exercise: 36.8 ± 0.1°C, 48.1 ± 1.6% relative humidity, and wind speed by fan of 2.54 m/s. All clocks and stopwatches were removed from subject view.
Tre and skin temperatures (Tsk) were recorded every 4 min, whereas HR was obtained at 2-min intervals during exercise. Arterial blood pressure, forearm skin blood flow (SkBF),
O2, carbon dioxide production (
CO2), respiratory quotient (R), respiratory rate (RR), pulmonary ventilation (
E), and cardiac output (
) were measured at 0, 5, 15, 30, 45, and 60 min of exercise. Blood samples (5 ml) were taken at 0, 5, 15, 30, 45, and 60 min of exercise, and a final blood sample (25 ml) was drawn immediately after the end of exercise.
Thermoregulatory measurements. Tre was measured by using a rectal thermistor (model 401, Yellow Springs Instruments, Yellow Springs, OH) inserted 10 cm past the external anal sphincter. Tsk were recorded via skin thermistors (model 409, Yellow Springs Instruments) at four sites: chest, triceps, thigh, and calf. Mean-weighted Tsk was calculated according to the equation of Ramanathan [Tsk = 0.2 (Tchest + Ttriceps) + 0.3 (Tthigh + Tcalf), where T is temperature] (39). Forearm SkBF was measured for 2 min with a laser Doppler flowmeter for microvascular perfusion (model Periflux PF2B, Perimed, Stockholm, Sweden). During the measurement, subjects rested their forearm in a neutral position with 90° flexion of the elbow. Data were expressed as cutaneous vascular conductance (CVC) by dividing SkBF, in volts, over mean arterial pressure (MAP), in 100 mmHg. Whole body sweat rate during exercise was calculated from body weight changes, corrected for estimated respiratory water losses (35), blood sample volume, and urine output.
Cardiovascular variables.
HR was measured by a lead I configuration, using a telemetric cardiotachometer (model Vantage XL, Polar Electro). Breath-by-breath analysis of the expired gases was performed with an open-circuit respiratory apparatus (model CPXD, MedGraphics Cardiopulmonary Exercise System) to determine
O2,
CO2, R, RR, and
E.
was measured via CO2 rebreathing, employing the exponential method (1, 10).
O2 and
CO2 were measured, as described above, for 3 min before each rebreathing procedure. To calculate stroke volume (SV), HR was recorded just before the onset of the rebreathing technique. Arterial systolic (SBP) and diastolic blood pressures (DBP) also were measured with an aneroid sphygmomanometer and stethoscope. MAP was calculated as shown in the following formula: MAP = (SBP DBP)/3 + DBP.
Blood collections. All blood samples were drawn without stasis at the points described above. From the 5-ml blood samples, a 4-ml aliquot was transferred to a test tube containing lithium heparin to determine OsmP, plasma sodium concentration ([Na+]P), plasma potassium concentration, plasma glucose concentration, plasma lactate concentration, total plasma proteins (TPP), and plasma Aldo concentration ([Aldo]P). The remaining aliquot (1 ml) was analyzed immediately for hematocrit (Hct) and hemoglobin (Hb). From the 25-ml blood sample, a 5-ml aliquot was treated as just described. From the remaining sample, a 7-ml aliquot was transferred into an EDTA-treated test tube for plasma AVP ([AVP]P) and glycerol ([Glyc]P) analysis. A separate 5-ml aliquot was transferred into a chilled EDTA-treated test tube that contained 2,000 kallikrein-inhibitor units of aprotinin (Sigma Diagnostics, St. Louis, MO) for plasma atriopeptin ([AP]P) analysis. An 8-ml aliquot was transferred into a chilled EDTA-treated tube for plasma renin activity (PRA) analysis. These samples were centrifuged immediately at 1,800 g and 4°C for 12 min. Plasma samples for hormonal assays were refrigerated at 80°C for later analysis.
Blood and urine analyses.
USG and TPP were measured by refractometer (model A300CL, Spartan). Hct was determined in triplicate from whole blood by the microcapillary technique, following centrifugation for 4 min at 9,500 g. No corrections were made for trapped plasma or for peripheral venous sampling. Hb was measured in triplicate from whole blood with the cyanmethemoglobin technique (Sigma Diagnostics). Percent changes in plasma volume were calculated with the following formula (11):
![]() |
PV is percent change of plasma volume, subscript B is before (control), and subscript A is after (experimental). OsmP and OsmU were determined in duplicate by freezing point depression the same day (model 3DII, Advanced Digimatic Osmometer, Norwood, MA). [Na+]P and plasma potassium concentration were determined by ion-sensitive electrodes on fresh plasma samples (model 984-S, AVL Scientific, Roswell, GA). Plasma glucose and lactate concentrations were determined in triplicate with an enzymatic technique (model 2003, Yellow Springs Instruments). [Glyc]P was measured in duplicate with a colorimetric technique (Sigma Diagnostics). [AVP]P was determined by a commercially available radioimmunoassay kit (Nichols Institute, San Juan Capistrano, CA). The within- and between-assay coefficients of variation for [AVP]P at midrange (13 pg/ml) were 1.8 and 5.8%, respectively. The sensitivity of the assay and the average extraction recovery were 1.3 pg/ml and 63.8%, respectively. PRA was evaluated in duplicate by radioimmunochemical determination of plasma angiotensin I, generated during 1 h of incubation at pH 6.0 (Incstar, Stillwater, MN). The within- and between-assay coefficients of variation of this assay at midrange (1.2 ng·l1·s1) were 4.6 and 4.8%, respectively. The sensitivity of the assay was 0.05 ng·l1·s1. [AP]P was determined by a radioimmunoassay technique (Peninsula Laboratories, Belmont, CA), after extraction on octadecylsilane C18 cartridges (Sep-Pak C18, Waters Associates, Milford, MA). The coefficient of variation of the assay was <5%. [Aldo]P was determined with a radioimmunoassay technique (Coat-A-Count, Diagnostic Products, Los Angeles, CA) that had a within-assay coefficient of variation for the mid- (395 pmol/l) and the high-range (1,020 pmol/l) of 3.3 and 1.9%, respectively. The sensitivity of the assay was 44 pmol/l. To reduce interassay variations, each subject's plasma samples were analyzed within the same assay run. All hormonal analyses were performed in duplicate. Statistical Analysis
Statistical evaluation of the data was accomplished with a two-way analysis of variance with repeated measures (treatment x time). Significant differences between the means were determined by Newman-Keuls post hoc test. Statistical differences were determined at the P < 0.05 level of confidence. All values were reported as means ± SE.
| RESULTS |
|---|
|
|
|---|
None of our subjects reported nausea, headache, or gastrointestinal problems during, or the 24 h following, G. One subject was stopped by the investigators during the G exercise test (time: 51 min and 45 s), as his core temperature reached 39.5° for >5 min (see criteria for termination in Experimental Protocol section).
Exercise time to exhaustion during G (32.5 ± 3.8 min) was 19% longer than during W (27.1 ± 3.3 min) and 72% longer than during NF (18.9 ± 2.7 min). Whereas seven out of the eight subjects exercised longer in G than in W, all subjects exercised longer in G and W than in NF. However, no differences were observed among the three trials for
O2, R, VE, or RR, both at rest and during exercise (Table 2).
|
Glycerol ingestion significantly increased (P < 0.05) [Glyc]P by
100 times (from 0.06 ± 0.01 to 9.94 ± 0.23 mmol/l) above NF (from 0.06 ± 0.01 to 0.08 ± 0.02 mmol/l) and W (from 0.06 ± 0.01 to 0.11 ± 0.04 mmol/l). Glycerol rehydration induced a higher level of OsmP than W at 0, 10, and 15 min of exercise and immediately postexercise (Fig. 1). However, [Na+]P was lower (P < 0.05) during G than W. [Na+]P during exercise was significantly higher for NF (P < 0.05) than both G and W (Fig. 1). TPP also was higher before and during exercise during NF (vs. G and W). Rehydration with glycerol significantly increased plasma volume (vs. W and NF; P < 0.05), and those differences were maintained throughout the exercise test (Fig. 1). Plasma glucose did not change significantly during any of the trials (Table 2), but was higher than the 15-min value during all trials. However, at 15 min of exercise and immediately postexercise, plasma glucose was significantly higher during NF compared with G and W. During NF, plasma lactate was higher than G and W at 15 min of exercise, whereas immediately postexercise this was true only compared with G (Table 2).
|
was maintained to a similar level from 5 min (NF: 21.0 ± 0.8, W: 20.6 ± 0.9, and G: 21.4 ± 0.8 l/min) to 15 min of exercise (NF: 20.0 ± 0.7, W: 21.0 ± 0.9, and G: 20.5 ± 0.8 l/min) for all trials. HR responses during exercise (Fig. 2) were not different between the G and W trials (P > 0.05). However, during the first 15 min of NF, HR was significantly higher than both the G and W values. HR at the end of the exercise test did not differ among trials. The SV at 15 min of exercise (Fig. 2) for NF was significantly (P < 0.05) lower than the G and W. During the G, there was a slight trend to maintain a higher SV than for W, but the difference was not statistically significant. We were unable to collect enough
data after 15 min, since several subjects stopped exercising before the 30-min mark.
|
Tre (Fig. 3) was significantly elevated (P < 0.05) during NF compared with G and W at 0, 4, 8, and 12 min of exercise. Tsk (Fig. 3) was significantly higher before the beginning of exercise in NF, but not different during exercise. SkBF and CVC were similar among the three experimental trials immediately before the exercise test (Fig. 4). During exercise, however, both SkBF and CVC were significantly higher (P < 0.05) during G vs. W and NF. Sweating was higher (P < 0.05) during G and W (G: 1,426 ± 152 ml and W: 1,395 ± 128 ml) than NF (798 ± 72 ml).
|
|
[AVP]P was significantly decreased after rehydration during G and W, but increased (P < 0.05) in response to exercise for all of the trials. The postexercise level of vasopressin for NF was significantly higher (P < 0.05) than for G and W (Fig. 5). [AP]P level was similar before rehydration and did not change during rehydration and exercise (Fig. 5).
|
|
| DISCUSSION |
|---|
|
|
|---|
Similar improvements in exercise time to exhaustion have been observed in the only other study in which glycerol was used as a rehydration agent (44), as well as in a hyperhydration study (36). Increase in exercise performance has been observed in some studies that utilized glycerol-induced overhydration before exercise (2, 9, 19), whereas others reported no performance improvement (20, 29, 31, 48). Although previous glycerol-induced overhydration studies have reported gastrointestinal discomfort, headaches, or even blurred vision (9, 25, 26), in our study, none of the subjects experienced any of those symptoms during G or the 24 h following the study. The absence of side effects has been also shown by others (27, 36, 40), and it has been speculated that high-concentration glycerol solutions (i.e., 50%) are likely to induce these symptoms.
Although rehydration during G did not induce a statistically significant better fluid balance compared with W, the small difference in hydration (due to smaller urinary output) may have provided physiologically greater body water "availability" during the glycerol trial. Furthermore, since volunteers exercised more during G but sweated similarly with W, we found that the rate of dehydration was reduced. Glycerol, on the other hand, is a solute that increases the tonicity of blood, and, although 2 liters of water were consumed, the 100-fold increase in plasma glycerol (Table 2) led to maintenance of the dehydration-induced elevation of Osmp. This osmotic effect, along with a slight improvement in hydration level, could induce the increased plasma volume observed during G compared with W. A similar response of plasma volume has been reported in other glycerol studies when plasma volume changes were calculated from Hct and Hb values, like in the present study (21, 29, 37, 44), or with Evans blue dilution technique (21).
Both Montner et al. (36) and Anderson et al. (2) indicated that glycerol-induced hyperhydration maintained HR at a lower level than a placebo. In the present study, although plasma volume for G was always greater than that for W, HR,
O2, blood pressure, and SV were not significantly different (G vs. W), although SV showed a nonsignificant trend to be higher during G (Fig. 2). It should be noted that we were unable to measure SV for all subjects after 15 min of exercise, since few of the volunteers managed to reach the 30-min time point at which the CO2 rebreathing maneuver was performed for the SV estimation (NF: 1, G: 5, and W: 3 subjects). We speculate that SV would have been higher in the G compared with W and NF at a later exercise stage, when cardiovascular strain was likely greater. Based on the first 15 min of exercise, our data are in agreement with a previous study by Latzka et al. (26), in which glycerol-induced hyperhydration before uncompensable exercise-heat stress offered no cardiovascular advantage compared with water-induced hyperhydration.
It was hypothesized that glycerol-related ergogenicity could enhance thermoregulatory responses, despite the fact that most studies have not reported thermoregulatory benefits (9, 19, 36, 44). In the present study, because the environmental temperature was always higher than the Tsk, sweat evaporation was the only means of heat dissipation. In contrast to the work of Lyon et al. (28), which reported that glycerol-induced hyperhydration increased sweating and decreased exercise core temperature, no difference was found in the sweat rates of W and G.
Glycerol is a gluconeogenic substance that can be metabolized in the liver and provides energy. Studies in experimental animals have shown that rats fed with high doses of glycerol performed better: they were protected from hypoglycemia and exhibited both liver and muscle glycogen sparing (46). This finding was not reported for humans, during 90 min of continuous running (34), cycling to exhaustion for
90 min (15), or even cycling to exhaustion (8092 min) following a 36-h fast (32). These data suggest that the human liver may not be able to metabolize glycerol fast enough to provide sufficient energy during intense exercise. Similarly, we found no differences between G and W in plasma glucose, lactate,
O2, and R, indicating that glycerol did not contribute substantially as an energy substrate.
In the present study, glycerol ingestion (G) altered fluid-regulating hormone responses to exercise in the heat (AVP, AP, and Aldo) and PRA in ways that were not observed when water alone was consumed (W). Glycerol increased OsmP; therefore, we expected a consequent increase in plasma AVP (42) (i.e., osmoreceptors are potent stimulators of AVP), despite a plasma volume increase that could otherwise hamper AVP secretion (41). We also considered the observation that the supraoptic and paraventricular nuclei of the hypothalamus are more sensitive to sodium than to substances like glycerol, glucose, or urea (14). At the end of exercise during the NF trial, however, AVP was approximately three times greater than G and W, likely because of a dehydration-induced hyperosmotic-hypernatremic hypovolemia (22, 30).
AP tended to decrease with rehydration and increase in response to exercise (P > 0.05). This may have occurred because plasma AP increases in response to atrial stretch (16). Freund et al. (13) reported an increased [AP]P as a result of maximal exercise in both trained and untrained subjects, whereas Kraemer et al. (24) reported that submaximal exercise (71% maximum
O2) did not alter [AP]P. In the present study, AP remained unchanged during exercise, suggesting that submaximal exercise in the heat, with or without glycerol, is not a potent secretory stimulus. In agreement with this finding, Freund et al. (14) showed that glycerol did not affect ANP and other fluid-regulating hormones.
PRA decreased during both rehydration conditions (P < 0.05), whereas Aldo did not change significantly. In response to exercise, both PRA and Aldo increased significantly as previously reported (8), but no changes were found among the trials. Brandenberger et al. (5) also observed that the initial state of hydration does not affect exercise-induced responses of Aldo and PRA.
In conclusion, this study supported the hypothesis that rehydration with glycerol increased exercise time to exhaustion during intensive cycling in the heat, likely by maintaining greater plasma volume. Glycerol did not provide significant cardiovascular or thermoregulatory advantages, although CVC was significantly increased. Furthermore, glycerol did not have a significant effect on fluid-regulating hormones, before or during exercise.
| GRANTS |
|---|
|
|
|---|
| ACKNOWLEDGMENTS |
|---|
|
|
|---|
| FOOTNOTES |
|---|
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
| REFERENCES |
|---|
|
|
|---|
CO2 from the exponential CO2 rise during rebreathing. J Appl Physiol 13: 159164, 1958.This article has been cited by other articles:
![]() |
B. Murray Hydration and Physical Performance J. Am. Coll. Nutr., October 1, 2007; 26(suppl_5): 542S - 548S. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |